KIT and acute myeloid leukemia: Mutations in signaling mediators such as receptor tyrosine kinases (e.g., FLT3 and KIT) and RAS-related molecules (e.g., N-RAS, K-RAS, PTPN11, or NF1) are found in adult and pediatric AML (8).